Article
The CpG island methylator phenotype in colorectal cancer: progress and problems.
Biochimica et biophysica acta - 1 Jan 2012
Hughes Laura A E, Khalid-de Bakker Carolina A J, Smits Kim M, van den Brandt Piet A, Jonkers Daisy, Ahuja Nita, Herman James G, Weijenberg Matty P, van Engeland Manon
Abstract excerpt
In recent years, attention has focused on the biology and potential clinical importance of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC). While it is generally well accepted that etiologically and clinically distinct subgroups exist in this disease, a precise definition of CIMP remains to be established. Here, we summarize existing literature that documents the prevalence of CIMP in CRC,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
